Unmet Needs in the Treatment of RA in the Era of Jak-i: IDRA (Italian Delphi Rheumatoid Arthritis) Consensus

por Caporali, R., Doria, A., Ferraccioli, G. F., Meroni, P. L., Zavaglia, D., Iannone, F.
Publicado 2018

Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial

por Smolen, J S, Emery, P, Ferraccioli, G F, Samborski, W, Berenbaum, F, Davies, O R, Koetse, W, Purcaru, O, Bennett, B, Burkhardt, H
Publicado 2015

Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis

por Tolusso, B, Frezza, D, Mattioli, C, Fedele, A L, Bosello, S, Faustini, F, Peluso, G, Giambra, V, Pietrapertosa, D, Morelli, A, Gremese, E, De Santis, M, Ferraccioli, G F
Publicado 2008

Preliminary classification criteria for the cryoglobulinaemic vasculitis

por De Vita, S, Soldano, F, Isola, M, Monti, G, Gabrielli, A, Tzioufas, A, Ferri, C, Ferraccioli, G F, Quartuccio, L, Corazza, L, De Marchi, G, Casals, M Ramos, Voulgarelis, M, Lenzi, M, Saccardo, F, Fraticelli, P, Mascia, M T, Sansonno, D, Cacoub, P, Tomsic, M, Tavoni, A, Pietrogrande, M, Zignego, A L, Scarpato, S, Mazzaro, C, Pioltelli, P, Steinfeld, S, Lamprecht, P, Bombardieri, S, Galli, M
Publicado 2011